Public Health Grant RMPDS recently secured a grant from the National Institute on Drug Abuse to extend research efforts. This indicates strong government and public health funding channels and a potential path for expanded research partnerships, funded studies, and contract work with public agencies or universities.

Toxicology Expertise With a long-standing reputation in toxicology and end-to-end services across the lifecycle of drugs and consumer products, there is a clear opportunity to upsell comprehensive safety, compliance, and risk management solutions to pharmaceutical manufacturers, regulators, and large healthcare systems seeking toxicology support.

Health Tech Stack Utilization of cloud and web technologies (AWS, Drupal), data/cybersecurity tools, and digital marketing platforms suggests readiness for scalable, tech-enabled services. This positions RMPDS as a candidate for digital collaboration, data sharing agreements, or joint grant-funded research platforms.

Industry Position As a Denver Health department with a focused niche in poison control, safety, and prevention, RMPDS can become a strategic partner for hospitals and health systems seeking toxin exposure management, patient safety programs, and regulatory compliance initiatives.

Growth Potential Revenue range indicates mid-market scale and potential for expansion through larger contracts, new service lines (education, prevention programs, and research collaborations), and multi-year deals with pharmaceutical, consumer products, and governmental entities.